No Data
No Data
Moderna Options Spot-On: On July 1st, 52,531 Contracts Were Traded, With 372.65K Open Interest
Bird Flu Vaccine Faces Hurdles Without Better Data, Critics Say
Alnylam, Lilly, AstraZeneca Among Best Performing Pharmas, Biotechs in Q2
Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio?
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space